Neuropeptide Y (NPY) receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Neuropeptide Y Receptors [156] ) are activated by the endogenous peptides neuropeptide Y, neuropeptide Y-(3-36), peptide YY, PYY-(3-36) and pancreatic polypeptide (PP). The receptor originally identified as the Y3 receptor has been identified as the CXCR4 chemokine recepter (originally named LESTR, [137] ). The y6 receptor is a functional gene product in mouse, absent in rat, but contains a frame-shift mutation in primates producing a truncated non-functional gene [83] . Many of the agonists exhibit differing degrees of selectivity dependent on the species examined. For example, the potency of PP is greater at the rat Y 4 receptor than at the human receptor [61]. In addition, many agonists lack selectivity for individual subtypes, but can exhibit comparable potency against pairs of NPY receptor subtypes, or have not been examined for activity at all subtypes. [ 125 I]-PYY or [ 125 I]-NPY can be used to label Y 1 , Y 2 , Y 5 and y 6 subtypes non-selectively, while [ 125 I] [cPP (1-7), NPY(19-23), Ala 31 , Aib 32 , Gln 34 ]hPP may be used to label Y 5 receptors preferentially (note that cPP denotes chicken peptide sequence and hPP is the human sequence).

